ARKADY NISMAN, PHARMD
Advertisement
Articles by ARKADY NISMAN, PHARMD
Given the relatively static rate of seizure freedom with the current antiepileptic drug (AED) armamentarium, a need remains for the development of new compounds to help enable more patients achieve seizure freedom. Fortunately, several investigational therapeutic agents and delivery systems are in phase 3 development, which are being investigated for the treatment of orphan diseases and focal-onset and generalized-onset seizures.
Advertisement
Latest Updated Articles
- A Further Look at Rational Polytherapy in Patients With Uncontrolled Epilepsy: Insights From a Post hoc Analysis of Adjunctive Cenobamate
Published: December 21st 2021 | Updated:
The Evolving Epilepsy Treatment Spectrum: A Review of Antiepileptic Drugs in Late DevelopmentPublished: October 29th 2019 | Updated:
- Increasing Awareness and Counseling on the Importance of Titration Schedules
Published: March 5th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5